ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,126.05
1.22%
Dow Jones
38,678.76
1.19%
US Dollar vs MXN
16.9935
0.12%
Brent Oil
83.085
-0.65%
Bitcoin
61,843.23
4.60%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. AMEX
  6. Ampio Pharmaceuticals Inc (AMPE)

  7. Ampio Pharmaceuticals Inc (AMPE) Noticias

AMPE

Ampio Pharmaceuticals (AMPE)

Ampio Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:AMEX:AMPE
FechaHoraFuenteTítuloSímboloCompañía
03/04/202413:33PR Newswire (US)Ampio Pharmaceuticals Received Audit Opinion with Going Concern ExplanationAMEX:AMPEAmpio Pharmaceuticals Inc
25/03/202416:00PR Newswire (US)Ampio Announces Voluntary Delisting and SEC DeregistrationAMEX:AMPEAmpio Pharmaceuticals Inc
04/03/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:AMPEAmpio Pharmaceuticals Inc
28/02/202414:49Edgar (US Regulatory)Form 8-K - Current reportAMEX:AMPEAmpio Pharmaceuticals Inc
28/02/202414:48Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsAMEX:AMPEAmpio Pharmaceuticals Inc
28/02/202414:46Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementAMEX:AMPEAmpio Pharmaceuticals Inc
28/02/202414:45Edgar (US Regulatory)Form RW - Registration Withdrawal RequestAMEX:AMPEAmpio Pharmaceuticals Inc
14/02/202416:45PR Newswire (US)Ampio Provides Update on Results from Pre-IND Enabling StudiesAMEX:AMPEAmpio Pharmaceuticals Inc
25/01/202415:18Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:AMPEAmpio Pharmaceuticals Inc
11/01/202415:15PR Newswire (US)Ampio Provides Litigation Update - Reports Settlement in Principle of Certain Pending Legal ActionsAMEX:AMPEAmpio Pharmaceuticals Inc
21/12/202315:25Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:AMPEAmpio Pharmaceuticals Inc
14/11/202315:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:AMPEAmpio Pharmaceuticals Inc
31/10/202308:00PR Newswire (US)Ampio Pharmaceuticals to Present at the Emerging Growth ConferenceAMEX:AMPEAmpio Pharmaceuticals Inc
05/10/202315:30PR Newswire (US)Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201AMEX:AMPEAmpio Pharmaceuticals Inc
18/09/202315:30Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933AMEX:AMPEAmpio Pharmaceuticals Inc
31/08/202305:30PR Newswire (US)Ampio Pharmaceuticals Announces Reverse Stock SplitAMEX:AMPEAmpio Pharmaceuticals Inc
15/08/202315:56Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:AMPEAmpio Pharmaceuticals Inc
13/07/202310:33Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:AMPEAmpio Pharmaceuticals Inc
14/06/202316:15Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:AMPEAmpio Pharmaceuticals Inc
09/06/202313:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:AMPEAmpio Pharmaceuticals Inc
26/05/202315:40Edgar (US Regulatory)Current Report Filing (8-k)AMEX:AMPEAmpio Pharmaceuticals Inc
26/05/202315:40PR Newswire (US)Ampio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common StockAMEX:AMPEAmpio Pharmaceuticals Inc
08/05/202315:54Edgar (US Regulatory)Quarterly Report (10-q)AMEX:AMPEAmpio Pharmaceuticals Inc
28/04/202316:14Edgar (US Regulatory)Amended Annual Report (10-k/a)AMEX:AMPEAmpio Pharmaceuticals Inc
18/04/202305:30PR Newswire (US)AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERSAMEX:AMPEAmpio Pharmaceuticals Inc
27/03/202315:43Edgar (US Regulatory)Annual Report (10-k)AMEX:AMPEAmpio Pharmaceuticals Inc
02/02/202311:37Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:AMPEAmpio Pharmaceuticals Inc
27/12/202216:44PR Newswire (US)Ampio Pharmaceuticals Regains Compliance with NYSE American Continued Listing StandardsAMEX:AMPEAmpio Pharmaceuticals Inc
17/11/202215:53PR Newswire (US)Ampio Pharmaceuticals Announces NYSE American Removal of Trading SuspensionAMEX:AMPEAmpio Pharmaceuticals Inc
08/11/202215:30PR Newswire (US)Ampio Pharmaceuticals Announces Fifteen-to-One Reverse Stock SplitAMEX:AMPEAmpio Pharmaceuticals Inc
 Showing the most relevant articles for your search:AMEX:AMPE

Su Consulta Reciente

COIN
SOLUSD
Solana
USOTC
BNPQY
BNP Paribas (QX)
NYSE
DIS
Walt Disney
COIN
BTCUSD
Bitcoin
NYSE
MCD
McDonalds
NASDAQ
AMZN
Amazon.com
USI
USTECH100
US Tech 100
USOTC
ADDYY
Adidas (QX)
NASDAQ
TSLA
Tesla
NASDAQ
AAPL
Apple
FX
EURMXN
Euro vs MXN
CCOM
US30
US 30
SPI
SP500
S&P 500
AMEX
XLV
Health Care Select Sector
NASDAQ
QQQ
Invesco QQQ Trust Series 1
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados